Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ammar Yaser Dab"'
Autor:
Mounica Vorla, Usman Ali Akbar, Daniya Sheikh, Shameera Shaik Masthan, Mounika Pusa, Aditya Bamboria, Saman Barham, Ammar Yaser Dab, Shaheryar Qazi, Adil Khan, Rana Usman Anwer, Oluwasegun Akinti, Faiz Anwer
Publikováno v:
Journal of Clinical Oncology. 40:e16005-e16005
e16005 Background: The prognosis of gastric cancer remains poor despite advances in diagnostic techniques, neoadjuvant chemo radiotherapy and surgery. This led to the development of Anti-Vascular Endothelial Growth Factor inhibitors (Anti-VEGF), whic
Autor:
Usman Ali Akbar, Mounica Vorla, Aqsa Ashraf, Keerthi Poladi, Shaheryar Qazi, Ammar Yaser Dab, Hafsah Ijaz, Ali Sibtain Azhar, Syeda Manahil Haider Jeoffrey, Muhammad Ali Ali Akhtar, Ali Momin
Publikováno v:
Journal of Clinical Oncology. 40:e13017-e13017
e13017 Background: Novel drugs that target HER2 receptors have shown promise in the treatment of Advanced breast carcinoma (BC). We study here the safety and efficacy of select monoclonal drugs (Mab) and tyrosine kinase inhibitors (TKIs) in the treat
Autor:
Mounica Vorla, Usman Ali Akbar, Aqsa Ashraf, Mounika Pusa, Saman Barham, Adil Khan, Daniya Sheikh, Ammar Yaser Dab, Shaheryar Qazi, Zeeshan Chaughtai, Faiz Anwer
Publikováno v:
Journal of Clinical Oncology. 40:e16020-e16020
e16020 Background: The poor prognosis of systemic chemotherapy in advanced gastric adenocarcinoma (GC) and gastroesophageal (GE) carcinoma prompted the development of novel agents such as anti-PDL-1 antibodies, which have the potential to overcome dr